These authors are considered as first coauthors.
Variant ATRX Syndrome with Dysfunction of ATRX and MAGT1 Genes
Article first published online: 10 NOV 2013
© 2013 WILEY PERIODICALS, INC.
Volume 35, Issue 1, pages 58–62, January 2014
How to Cite
Qiao, Y., Mondal, K., Trapani, V., Wen, J., Carpenter, G., Wildin, R., Price, E. M., Gibbons, R. J., Eichmeyer, J., Jiang, R., DuPont, B., Martell, S., Lewis, S. M. E., Robinson, W. P., O'Driscoll, M., Wolf, F. I., Zwick, M. E. and Rajcan-Separovic, E. (2014), Variant ATRX Syndrome with Dysfunction of ATRX and MAGT1 Genes. Hum. Mutat., 35: 58–62. doi: 10.1002/humu.22465
Contract grant sponsors: The Canadian Institutes for Health Research (CIHR) (MOP 74502; PI); The Michael Smith Foundation for Health Research.
Communicated by Hamish S. Scott
- Issue published online: 18 DEC 2013
- Article first published online: 10 NOV 2013
- Accepted manuscript online: 15 OCT 2013 11:02AM EST
- Manuscript Accepted: 2 OCT 2013
- Manuscript Received: 20 JUN 2013
- The Canadian Institutes for Health Research (CIHR). Grant Number: MOP 74502
- The Michael Smith Foundation for Health Research
Disclaimer: Supplementary materials have been peer-reviewed but not copyedited.
Supp. Figure S1. ATRX and MAGT1 mutations. A. Single nucleotide deletion in ATRX. B. Chromosome X array with MAGT1 CNV (enlarged in inset). C. Position of ATRX single nucleotide deletion in exon 36 and MAGT1 CNV in intron 3 which contains an alternative splice site and overlaps 3’UTR of isoform 2, UCSC, hg18. D. Schematic diagram of the ATRX gene (not to scale). The blue horizontal line represents exon 36. The mutation discovered in this study is indicated with an arrow. The principal domains, the zinc finger motif (ADD) and the highly conserved helicase motif, are indicated as are the conserved P box (P) and a glutamine-rich region (Q). Total number of mutations in ADD, helicase and the C terminus is indicated by numbers inside circles. A total of 6 different constitutional mutations have previously been reported near the C-terminus of ATRX, all of which lead to protein truncation [Gibbons et al., 2008].
Supp. Figure S2. RT-PCR products for MAGT1 gene. C1 and C2 are controls.
Supp. Figure S3. ATG4 RNA (A) and protein (B) expression. C = controls.
Supp. Table S1. Summary of clinical findings
Supp. Table S2. Summary of genetic investigations
Supp. Table S3. Analysis of genetic variants detected by exome sequencing
Supp. Table S4. Candidate chromosome X variants
Supp. Table S5. Primers used for Sanger sequencing
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.